It deals with issues related to the effects of intellectual property on public health, cyberlaw and e-commerce, and competition policy.
It has supported free software in government, open access for the Internet, and privacy regulation.
KEI works on access to medicines, including a major effort on compulsory licensing of patents.
Beginning in 2002, CPTech began to work with Tim Hubbard and others on a new trade framework for medical research and development (R&D).
It supports providing reasonable benefits and incentives to creators and owners, while making essential knowledge and goods accessible and affordable to the broadest possible public.